Literature DB >> 10384880

Mice lacking NT-3, and its receptor TrkC, exhibit profound deficiencies in CNS glial cells.

M A Kahn1, S Kumar, D Liebl, R Chang, L F Parada, J De Vellis.   

Abstract

Neurotrophin-3 (NT-3) and its receptor TrkC are known to be important for neuronal survival. More recently, NT-3 has been implicated as playing a role in oligodendrocyte (OL) proliferation and survival in vitro. Examination of NT-3 and TrkC knockout mice revealed a reduction in NT-3-dependent neurons. To date, no study has examined alterations in glial cell populations in these knockout mice. In this report, we demonstrate a decline in OL progenitor cell numbers within the CNS of NT-3 and TrkC knockout mice. We also observed that immature and mature OL-specific markers were attenuated in the NT-3 and TrkC knockout animals. Deficiencies in other CNS glial cells, including astrocytes and ameboid microglia, were also observed. The subventricular zone (SVZ), a highly proliferative region for progenitor glial cells, was reduced in size. Furthermore, a nuclear-specific stain revealed a decline in the numbers of pyknotic nuclei in and around the SVZ of the knockout mice. These data will support an in vivo NT-3-dependent mechanism for the normal development of CNS glial cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10384880

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  26 in total

1.  Adenovirus vector-directed expression of the neurotrophin-3 receptor (TrkC) in mouse astrocytes.

Authors:  N Rubio; J Abad-Rodriguez
Journal:  J Neurovirol       Date:  2001-02       Impact factor: 2.643

2.  Signaling by FGF Receptor 2, Not FGF Receptor 1, Regulates Myelin Thickness through Activation of ERK1/2-MAPK, Which Promotes mTORC1 Activity in an Akt-Independent Manner.

Authors:  Miki Furusho; Akihiro Ishii; Rashmi Bansal
Journal:  J Neurosci       Date:  2017-02-13       Impact factor: 6.167

3.  Regulation of microglial development: a novel role for thyroid hormone.

Authors:  F R Lima; A Gervais; C Colin; M Izembart; V M Neto; M Mallat
Journal:  J Neurosci       Date:  2001-03-15       Impact factor: 6.167

4.  Astrocytes induce proliferation of oligodendrocyte progenitor cells via connexin 47-mediated activation of the ERK/Id4 pathway.

Authors:  Zhaoyu Liu; Dan Xu; Shang Wang; Yi Chen; Zhen Li; Xiaoyan Gao; Lu Jiang; Yong Tang; Yan Peng
Journal:  Cell Cycle       Date:  2017-02-22       Impact factor: 4.534

Review 5.  Promoting myelin repair and return of function in multiple sclerosis.

Authors:  Jingya Zhang; Elisabeth G Kramer; Linnea Asp; Dipankar J Dutta; Kristina Navrazhina; Trinh Pham; John N Mariani; Azeb Tadesse Argaw; Carmen V Melendez-Vasquez; Gareth R John
Journal:  FEBS Lett       Date:  2011-08-18       Impact factor: 4.124

6.  Combination of growth factors enhances remyelination in a cuprizone-induced demyelination mouse model.

Authors:  Shalini Kumar; Juan Carlos Biancotti; Masahiro Yamaguchi; Jean de Vellis
Journal:  Neurochem Res       Date:  2006-12-21       Impact factor: 3.996

Review 7.  Neurotrophic factor control of adult SVZ neurogenesis.

Authors:  Kevin G Bath; Francis S Lee
Journal:  Dev Neurobiol       Date:  2010-04       Impact factor: 3.964

8.  Proneurotrophin-3 is a neuronal apoptotic ligand: evidence for retrograde-directed cell killing.

Authors:  Hiroko Yano; Risa Torkin; Laura Andrés Martin; Moses V Chao; Kenneth K Teng
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

9.  ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination.

Authors:  Akihiro Ishii; Sharyl L Fyffe-Maricich; Miki Furusho; Robert H Miller; Rashmi Bansal
Journal:  J Neurosci       Date:  2012-06-27       Impact factor: 6.167

10.  Neurotrophin-3 targets the translational initiation machinery in oligodendrocytes.

Authors:  Rochelle P Coelho; Larra M Yuelling; Babette Fuss; Carmen Sato-Bigbee
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.